Daily 2X VIX ST ETN Velocityshares (TVIX) 7.07 $TVIX The

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2015 at 2:41 PM

Daily 2X VIX ST ETN Velocityshares (TVIX) 7.07 $TVIX

The Road Ahead - Research on Ekso Bionics Holdings, Marilynjean Interactive, Credit Suisse - VelocityShares Daily 2x VIX Short Term ETN and Century Aluminum
ACCESSWIRE - Mon Nov 02, 6:51AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ekso Bionics Holdings Inc. (OTC: EKSO), Dominovas Energy Corp. (OTC: DNRG), Credit Suisse AG - VelocityShares Daily 2x VIX Short Term ETN (NASDAQ: TVIX) and Century Aluminum Co. (NASDAQ: CENX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
CENX: 3.54 (-0.26), TVIX: 7.07 (+0.45)

TVIX Due Diligence Report: Fear is Growing, TVIX to Follow
ACCESSWIRE - Mon Sep 21, 7:15AM CDT
NEW YORK, NY / ACCESSWIRE / September 21, 2015 / Credit Suisse Ag - VelocityShares Daily 2x VIX Short Term ETN (NASDAQ: TVIX) an exchange-traded note (ETN) tracking the CBOE Volatility Index (VIX) has certainly followed a rollercoaster path over the past month. With the Fed rate decision looming, the ETN experienced a massive upward move before falling just before the decision. Janet Yellen announced that the rate will remain unchanged and focused on the volatility in the Emerging Markets. This drove a small recovery in TVIX on Friday, moving the stock up 25%. There certainly may be more gains to come due to the upcoming economic calendar and instability in Global markets.
TVIX: 7.07 (+0.45)

Leveraged Volatility ETFs Gain Over 100% from Global Rout
Sweta Killa - Zacks Investment Research - Tue Aug 25, 9:20AM CDT
China-led global growth fears and a brutal plunge in oil prices continued to flare up volatility worldwide for the second week in a row.
TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), UVXY: 32.01 (+2.09)

Volatility ETFs Jump on Rising Global Fears
Sweta Killa - Zacks Investment Research - Fri Aug 21, 9:45AM CDT
This seems a good time to remain invested in the volatility market.
VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), UVXY: 32.03 (+2.11), VIIX: 27.64 (+0.97), CVOL: 0.46 (-0.01), VIXY: 13.60 (+0.47)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jul 06, 4:38PM CDT

TVIX: 7.07 (+0.45), NFBK: 15.60 (+0.06), SFBS: 47.33 (+0.54), ANIP: 42.99 (+1.74), SHLM: 32.85 (+0.44), KTOS: 4.61 (-0.12), LONG: 17.09 (+0.04), COLM: 46.98 (-2.82)

Volatility Surges 35% On Grexit Fears: It's Time To (Start) Shorting The VIX
Force Majeure - at Seeking Alpha - Wed Jul 01, 3:18AM CDT

VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), SPY: 205.85 (+0.23), VXX: 20.47 (+0.72), ZIV: 41.64 (-0.29), VXZ: 11.36 (+0.11), VXDN: 20.90 (+0.01), XIV: 27.63 (-1.08)

Are HFTs Responsible For Low Market Volatility?
Cam Hui, CFA - at Seeking Alpha - Sat Jun 27, 7:30AM CDT
I received a number of thoughtful responses from my last post about falling equity volatility (see Will the quants blow up the markets again? ). One of the themes that was repeated several times in the comments pointed to HFT algos as a possible...
VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), IVOP: 37.84 (unch), UVXY: 32.03 (+2.11), XIV: 27.63 (-1.08), SVXY: 54.06 (-2.10), SPY: 205.85 (+0.23), DIA: 175.47 (+0.45), VIIX: 27.64 (+0.97), VXDN: 20.90 (+0.01), XXV: 38.13 (-0.08), VIXY: 13.60 (+0.47)

Summer Correction On The Horizon
Carbide Capital Inc. - Seeking Alpha - Fri Jun 26, 3:02PM CDT
As summer gets into full swing and markets continue to obsess over the Fed and Greece, we are seeing some interesting dynamics occur. On the one hand, economic data has been improving in the United States. Consumer spending just had its largest...
TVIX: 7.07 (+0.45), SPY: 205.85 (+0.23), VXX: 20.47 (+0.72), IYT: 145.79 (+0.87), XIV: 27.63 (-1.08)

Volatility vanishes from U.S. equities
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 9:03AM CDT

VXUP: 18.84 (-4.76), TVIZ: 14.35 (-0.06), TVIX: 7.07 (+0.45), VIXM: 55.26 (+0.34), XVIX: 16.15 (unch), VXX: 20.47 (+0.72), IVOP: 37.84 (unch), UVXY: 32.03 (+2.11), VXZ: 11.36 (+0.11), CVOL: 0.46 (-0.01), XIV: 27.63 (-1.08), SVXY: 54.06 (-2.10), XVZ: 26.62 (-0.42), ZIV: 41.64 (-0.29), VIIX: 27.64 (+0.97), VXDN: 20.90 (+0.01), VIIZ: 15.39 (-0.85), XXV: 38.13 (-0.08), VIXY: 13.60 (+0.47)

Credit Suisse AG Announces the Reverse Split of its TVIX ETN
PR Newswire - Tue Jun 16, 7:15PM CDT
Credit Suisse AG announced today that it will implement a 1-for-10 reverse split of its VelocityShares(TM) Daily 2x VIX Short Term ETN ("TVIX"

, expected to be effective as of June 23, 2015.
TVIX: 7.07 (+0.45), CS: 23.08 (-0.06)

How Volatility And The Roll Yield Contribute To The Price Action Of VXX In Different Market Environments
David Easter - at Seeking Alpha - Fri Jun 05, 11:27AM CDT

TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), UVXY: 32.03 (+2.11), SVXY: 54.06 (-2.10), XIV: 27.63 (-1.08)

Why VXX Loses Value Over Time: Another Look
David Easter - at Seeking Alpha - Thu May 28, 9:00AM CDT

TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), UVXY: 32.03 (+2.11), XIV: 27.63 (-1.08), SVXY: 54.06 (-2.10)

AccuShares will launch 2 VIX ETFs on May 19th
Seeking Alpha - at Seeking Alpha - Mon May 18, 11:25AM CDT

TVIZ: 14.35 (-0.06), VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), VIXM: 55.26 (+0.34), XVIX: 16.15 (unch), VXX: 20.47 (+0.72), IVOP: 37.84 (unch), UVXY: 32.03 (+2.11), VXZ: 11.36 (+0.11), CVOL: 0.46 (-0.01), XIV: 27.63 (-1.08), SVXY: 54.06 (-2.10), XVZ: 26.62 (-0.42), ZIV: 41.64 (-0.29), VIIX: 27.64 (+0.97), VIIZ: 15.39 (-0.85), VXDN: 20.90 (+0.01), XXV: 38.13 (-0.08), VIXY: 13.60 (+0.47)

Two new VIX ETFs to launch on Nasdaq
Seeking Alpha - at Seeking Alpha - Mon May 18, 11:09AM CDT

TVIZ: 14.35 (-0.06), VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), VIXM: 55.26 (+0.34), XVIX: 16.15 (unch), VXX: 20.47 (+0.72), IVOP: 37.84 (unch), UVXY: 32.03 (+2.11), VXZ: 11.36 (+0.11), CVOL: 0.46 (-0.01), XIV: 27.63 (-1.08), SVXY: 54.06 (-2.10), XVZ: 26.62 (-0.42), ZIV: 41.64 (-0.29), VIIX: 27.64 (+0.97), VIIZ: 15.39 (-0.85), VXDN: 20.90 (+0.01), XXV: 38.13 (-0.08), VIXY: 13.60 (+0.47)

A New Spot VIX ETF Compared To Tried And Tested VIX Futures Fund
Nathan Buehler - at Seeking Alpha - Sat May 16, 5:09AM CDT

VXUP: 18.84 (-4.76), TVIX: 7.07 (+0.45), VXX: 20.47 (+0.72), UVXY: 32.03 (+2.11)

Is There Any Truth To The Adage 'Sell In May And Go Away'? A 21st Century Take On A 19th Century Rhyme
Force Majeure - at Seeking Alpha - Thu Apr 30, 4:38AM CDT

TVIX: 7.07 (+0.45), SPY: 205.85 (+0.23), VXX: 20.47 (+0.72), UVXY: 32.03 (+2.11), IWM: 114.97 (-0.08)

Will The European Market Rally Be Derailed By Greece?
Marvin Hah - at Seeking Alpha - Sun Apr 19, 6:13AM CDT

FEZ: 35.76 (+0.25), VGK: 50.96 (+0.20), DBEU: 26.74 (+0.19), VXX: 20.47 (+0.72), IVOP: 37.84 (unch), UVXY: 32.03 (+2.11), FIEU: 104.76 (+2.15), FEP: 29.49 (+0.16), FEUZ: 30.43 (-0.70), IEUR: 43.20 (+0.18), UPV: 41.63 (+1.14), XIV: 27.63 (-1.08), FEU: 32.95 (+0.33), HEDJ: 61.67 (+0.62), EPV: 57.17 (-0.47), DBEZ: 27.42 (+0.28), VIIX: 27.64 (+0.97), HEZU: 27.30 (+0.23), TVIX: 7.07 (+0.45), ADRU: 21.31 (+0.29), EURL: 25.90 (+0.32), FEEU: 100.51 (+1.73), EZU: 36.05 (+0.20), SVXY: 54.06 (-2.10), SBEU: 24.44 (-0.50), IEV: 41.29 (+0.21), XXV: 38.13 (-0.08), VIXY: 13.60 (+0.47)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

China's 15th Plan: Key Moves in the Capital Markets

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

CStone's CS2009: A Leap in Cancer Treatment Validated

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

NOTHING NINE's Global Ambitions: Paris Show's Impact

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Superteam Wheels Rides Into Spain with RACEIT Deal

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Zinzino Eyes European Market With New Botanical Line

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...